People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
It is backed by a caution inactive ingredient profile, while product-specific testing is not currently verified by SuppCo
Affecting digestion and satiety: GLP-1 slows gastric emptying, allowing food to remain in the stomach longer
Some individuals may unintentionally skip meals, reduce protein intake, or fall behind on hydration without noticing at first
Step 8: Withdraw and dispose Release the skin fold